House Reps to FDA: Regulatory Changes for Devices Must Be More Transparent

MassDevice -- A bipartisan group of U.S. House representatives send a letter to the Food & Drug Administration asking for more transparency and greater detail from the watchdog agency as it implements changes to the 510(k) medical device clearance process.